Unjha Formulations Reports Flat Q3 Performance Amid Mixed Financial Results for FY24-25
Unjha Formulations has released its financial results for the quarter ending December 2024, showing a flat performance for Q3 FY24-25. While the Profit After Tax for the nine-month period increased significantly, half-yearly net sales declined, highlighting a mixed financial outlook for the company.
Unjha Formulations, a microcap player in the Pharmaceuticals & Drugs industry, has recently reported its financial results for the quarter ending December 2024. The results, declared on February 4, 2025, indicate a flat financial performance for the third quarter of FY24-25. Notably, the company's evaluation has undergone a revision, with its score adjusting from 6 to 2 over the past three months.On a positive note, the Profit After Tax (PAT) for the nine-month period has shown an increase, reaching Rs 0.81 crore compared to Rs 0.27 crore in the preceding twelve months. This suggests that Unjha Formulations has surpassed its sales figures from the previous year within just nine months.
Conversely, the half-yearly net sales have presented challenges, recorded at Rs 7.54 crore, reflecting a year-on-year decline of 26.87%. This trend indicates a negative trajectory in near-term sales performance.
Overall, Unjha Formulations is navigating a complex financial landscape, with both positive developments in profitability and challenges in sales growth.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
